J
Janusz Milanowski
Researcher at Medical University of Lublin
Publications - 238
Citations - 3523
Janusz Milanowski is an academic researcher from Medical University of Lublin. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 25, co-authored 201 publications receiving 2930 citations.
Papers
More filters
Journal ArticleDOI
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial
Ulrich Gatzemeier,Anna Pluzanska,Aleksandra Szczesna,E. Kaukel,Jaromír Roubec,Flavio De Rosa,Janusz Milanowski,Hanna Karnicka-Mlodkowski,Miloš Pešek,Piotr Serwatowski,Rodryg Ramlau,Terezie Janaskova,Johan Vansteenkiste,János Strausz,Georgy M. Manikhas,Joachim von Pawel +15 more
TL;DR: Erlotinib with concurrent cisplatin and gemcitabine showed no survival benefit compared with chemotherapy alone in patients with chemotherapy-naïve advanced NSCLC.
Journal ArticleDOI
Pantoea agglomerans: a mysterious bacterium of evil and good. Part III. Deleterious effects: infections of humans, animals and plants.
TL;DR: Pantoea agglomerans, a bacterium associated with plants, is not an obligate infectious agent in humans, however, it could be a cause of opportunistic human infections, mostly by wound infection with plant material, or as a hospital-acquired infection, mostly in immunocompromised individuals.
Journal ArticleDOI
Phenotypes of organ involvement in sarcoidosis.
Jonas C. Schupp,Sandra Freitag-Wolf,Elena Bargagli,Violeta M. Mihailovic-Vucinic,Paola Rottoli,Aleksandar Grubanovic,Annegret Müller,Arne Jochens,Lukas Tittmann,Jasmin Schnerch,Carmela Olivieri,Annegret Fischer,Dragana Jovanovic,Snežana Filipovic,Jelica Videnovic-Ivanovic,Paul Bresser,René E. Jonkers,Kate O’Reilly,Ling-Pei Ho,Karoline I. Gaede,Peter Zabel,Anna Dubaniewicz,Ben G. Marshall,Robert Kieszko,Janusz Milanowski,Andreas Günther,Anette Weihrich,Martin Petrek,Vitezslav Kolek,Michael P. Keane,Sarah L. O’Beirne,Seamas C. Donnelly,Sigridur Olina Haraldsdottir,Kristin B. Jorundsdottir,Ulrich Costabel,Francesco Bonella,Benoit Wallaert,Christian Grah,Tatjana Peroš-Golubičić,Mauritio Luisetti,Zamir Kadija,Stefan Pabst,Christian Grohé,János Strausz,Martina Vasakova,Martina Sterclova,Ann B. Millar,Jiří Homolka,Alena Slováková,Y Kendrick,Anjali Crawshaw,Wim A. Wuyts,Lisa G. Spencer,Michael Pfeifer,Dominique Valeyre,Venerino Poletti,Hubertus Wirtz,Antje Prasse,Stefan Schreiber,Michael Krawczak,Joachim Müller-Quernheim +60 more
TL;DR: Five new clinical phenotypes of sarcoidosis have been identified by analysing organ manifestations of 1932 patients and will be useful to recruit homogenous cohorts in future biomedical studies.
Journal ArticleDOI
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations
Enriqueta Felip,Andrea Ardizzoni,Tudor Ciuleanu,Manuel Cobo,Konstantin Laktionov,Mária Szilasi,Raffaele Califano,Enric Carcereny,Richard Griffiths,Luis Paz-Ares,Renata Duchnowska,Miriam Alonso Garcia,Dolores Isla,Jacek Jassem,W. Appel,Janusz Milanowski,Jan P. van Meerbeeck,Juergen Wolf,Ang Li,Angelic Acevedo,Sanjay Popat,Sanjay Popat +21 more
TL;DR: In patients with ECOG PS 2, nivolumab had similar tolerability, but outcomes were worse, as expected in this difficult-to-treat, poor prognosis population, with OS outcomes consistent with phase 3 data.
Journal ArticleDOI
Pantoea agglomerans: a mysterious bacterium of evil and good. Part IV. Beneficial effects.
TL;DR: In conclusion, in spite of the proven pathologic role of P. agglomerans in causing occupational diseases of allergic and/or immunotoxic background and accidental infections, the beneficial traits of this species, and of related species of Pantoea genus, are of great value for potential use in many areas of biotechnology.